2 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Peter L Greenberg: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase II Cont. IV of ON 01910.Na in MDS w/ Trisomy 8/Intermed-1, 2/High Risk Myelodysplastic Syndromes | Completed | Peter L Greenberg | 13 | 2009-06-01 | 2020-03-25 | |
| A Study of Darbepoetin Alfa in Patients With Myelodysplastic Syndrome (MDS) Darbepoetin alfa - Blood Cancer, Myelodysplastic Syndromes | Phase 1 / Phase 2 | Completed | Peter L Greenberg | 21 | 2002-02-01 | 2013-02-04 |
Myelodysplastic Syndromes (2) · Hematologic Neoplasms (1)
Darbepoetin alfa (1)
United States (2)